Therapy Areas: Cardiovascular
Gan & Lee Pharmaceuticals launches third phase 3 trial of once-monthly bofanglutide
27 November 2025 - Chinese biopharmaceutical company Gan & Lee Pharmaceuticals Co., Ltd. (SHA: 603087) announced on Thursday that it has begun GRADUAL-3, its third large-scale phase 3 study of the...
Remington Medical's VascuChek 2.0 Cordless Bluetooth-Enabled Doppler Secures FDA Clearance
26 November 2025 - Remington Medical has confirmed that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its updated VascuChek® Doppler, marking the official commercial...
LivaNova secures higher Medicare reimbursement for VNS Therapy procedures
24 November 2025 - Medical technology company LivaNova PLC (Nasdaq: LIVN) announced that the U.S. Centers for Medicare & Medicaid Services (CMS) will assign VNS Therapy for drug-resistant epilepsy...
Probi launches new human and pet biotics ranges
19 November 2025 - Sweden-based biotics solutions company Probi, a subsidiary of German chemicals company Symrise AG (ETR: SY1), announced on Wednesday that it has expanded its portfolio with two new ...
Rona Therapeutics reveals RN0361 phase one clinical data at American Heart Association 2025 Scientific Sessions
10 November 2025 - Rona Therapeutics, a China-based company involved in developing next-generation RNAi therapeutics, announced on Sunday its phase one clinical data for RN0361, a long-acting Apolipop...
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
20 October 2025 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) on Monday announced new results from the FLUNITY-HD study, published in The Lancet, confirming that its high-d...